Navigation Links
NeurogesX Reports Third Quarter 2008 Results
Date:11/6/2008

ckholders' equity:

Common stock 18 17

Additional paid-in capital 208,964 205,417

Deferred stock-based compensation (4) (15)

Accumulated other comprehensive income 55 51

Deficit accumulated during the development

stage (185,356) (164,109)

Total stockholders' equity 23,677 41,361

Total liabilities and stockholders' equity $32,254 $54,185

(1) The balance sheet at December 31, 2007 has been derived from the

audited consolidated financial statements at that date.

NeurogesX, Inc. The Ruth Group

Stephen Ghiglieri Stephanie Carrington / Sara Ephraim

Chief Financial Officer (investors)

(650) 358-3310 (646) 536-7017 / 7002

scarrington@theruthgroup.com

sephraim@theruthgroup.com

Jason Rando (media)

(646) 536-7025

jrando@theruthgroup.com


'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. NeurogesX Appoints New Director to the Board
3. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
7. NeurogesX, Inc. Announces $25 Million Private Placement
8. NeurogesX Closes $25 Million Private Placement
9. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
10. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
11. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Many of us take ... certain infants with rare, inherited mutations of certain ... of their impaired immune responses. Now, ... an important role for calcium signaling in immune ... the bacterium causing tuberculosis (TB). ...
(Date:5/4/2015)... , May 4, 2015 Tobira ... focused on the development and commercialization of novel ... the completion of its merger with Regado Biosciences, ... with the closing of the merger, Tobira raised ... of new investors and all current Tobira institutional ...
(Date:5/4/2015)... , May 4, 2015 /PRNewswire/ - JSS Medical Research Inc., a ... today that it concluded the acquisition of Max Neeman International (MNI), ... Additional regional offices are located in Ahmedabad, Bangalore ... . Through a US subsidiary, a regional office is located ... expansion is supported by the recent equity investment transaction into JSS ...
(Date:5/4/2015)... 2015   St. Jude Children,s Research Hospital ... tool for finding genetic alterations that play an ... to identify with whole-genome sequencing. The findings appear ... . The tool is an algorithm ... Regression Tree in Next Generation Sequencing. ...
Breaking Biology Technology:Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 2Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 4Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 5Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 6JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4Scientists dramatically improve method for finding common genetic alterations in tumors 2Scientists dramatically improve method for finding common genetic alterations in tumors 3Scientists dramatically improve method for finding common genetic alterations in tumors 4
... MISSISSAUGA, ON , Jan. 12 /PRNewswire-FirstCall/ - ... that YM BioSciences, previously announced proposal to acquire all the ... of Arrangement was subject to a positive vote of Cytopia ... At the Scheme Meeting held in Melbourne on ...
... ... to educate about the need for vascular screening in the form of noninvasive ultrasound tests. ... stroke, the abdominal aorta for aneurysms, and the legs for peripheral arterial disease. , ... Cleveland, OH (PRWEB) January 12, 2010 ...
... For the first time, physicists have convincingly demonstrated ... be quantum-mechanically entangled. The achievement is analogous to ... involves particles in circuitry instead of photons in ... offer potential routes to quantum computing and secure ...
Cached Biology Technology:YM BioSciences announces result of Cytopia shareholder vote 2YM BioSciences announces result of Cytopia shareholder vote 3YM BioSciences announces result of Cytopia shareholder vote 4Life Line Screening and Dr. Ken Kronhaus Work Together to Educate People About Vascular Screening 2Life Line Screening and Dr. Ken Kronhaus Work Together to Educate People About Vascular Screening 3
(Date:4/27/2015)... , April 27, 2015  For more than ... trade show has been the premier worldwide event for ... 2015 is a must-attend event for any local, national, ... into the emerging commercial markets and current applications of ... innovations of this projected $48 billion industry, and how ...
(Date:4/27/2015)... Apr. 27, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... pre-order customers the first week of May, 2015 and ... of May. Gino Pereira , ... for the company as Wocket® enters the consumer market. ...
(Date:4/27/2015)... Fla. , Apr. 27, 2015 Profile ... access control and security systems is pleased to announce ... company as a consultant and member of its scientific ... is widely known as a thought leader in technology-enhanced ... Learning Technology Group, and has published studies and books ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... that when enough bacteria get together in one place, they ... swim away. This type of behavior has been seen for ... an understanding of how to break up harmful bacterial biofilms, ... medical devices like artificial heart valves. Bacteria have ways ...
... SOUTH KOREA (September 5, 2012) Will the tiger go ... extinction like the American bison? The Wildlife Conservation ... are at a conservation crossroads calling for governments to take ... The list includes: the tiger, orangutans, Mekong giant catfish, ...
... 5, 2012 - A team of experts in mechanics, materials ... stretchy and tough gel that may pave the way to ... because its main ingredient is water, the new material is ... something much stronger. Not only can this new gel stretch ...
Cached Biology News:Bacteria on marine sponges can develop capacity to move and inhibit biofilm formation 2Wildlife Conservation Society releases list of Asian species at the conservation crossroads 2Tough gel stretches to 21 times its length, recoils, and heals itself 2Tough gel stretches to 21 times its length, recoils, and heals itself 3
BAFF-R (CT) BR3 Affinity Purified Polyclonal Antibody...
Goat polyclonal to NIR1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SWARGPPKFESVP, corresponding to C terminal amino acids 962-974 of NIR1. Entrez Gene ID: 83394 ...
PMM2 Immunogen: PMM2 (NP_000294, 47 a.a. ~ 112 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
HOXC11 Antibody...
Biology Products: